| Shamim Hashemi Nejad, MD | |
|
4445 Talbot Rd S, Renton, WA 98055-6219 | |
| (425) 690-3414 | |
| (425) 690-9414 |
| Full Name | Shamim Hashemi Nejad |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 21 Years |
| Location | 4445 Talbot Rd S, Renton, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124120761 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley Medical Center | Renton, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Medical Group-renton | 4183753965 | 408 |
News Archive
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
Family-based treatments are effective for substance abuse and conduct disorders in children and adolescents, according to a new, ten-year research review released this week. The treatment also helps reduce the behavior problems associated with attention deficit hyperactivity disorder (ADHD) and shows promise in treating depression and anxiety.
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.
Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos.
Nearly 15 percent of all chewing gum varieties sold promise to provide health-enhancing supplements to users, so Penn State researchers studied whether two vitamin-supplemented products were effective at delivering vitamins to the body. Their results validate the concept of gum as an effective delivery system for at least some vitamins.
› Verified 1 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139724 PECOS PAC ID: 9537072814 Enrollment ID: O20031112000189 |
News Archive
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
Family-based treatments are effective for substance abuse and conduct disorders in children and adolescents, according to a new, ten-year research review released this week. The treatment also helps reduce the behavior problems associated with attention deficit hyperactivity disorder (ADHD) and shows promise in treating depression and anxiety.
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.
Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos.
Nearly 15 percent of all chewing gum varieties sold promise to provide health-enhancing supplements to users, so Penn State researchers studied whether two vitamin-supplemented products were effective at delivering vitamins to the body. Their results validate the concept of gum as an effective delivery system for at least some vitamins.
› Verified 1 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
Family-based treatments are effective for substance abuse and conduct disorders in children and adolescents, according to a new, ten-year research review released this week. The treatment also helps reduce the behavior problems associated with attention deficit hyperactivity disorder (ADHD) and shows promise in treating depression and anxiety.
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.
Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos.
Nearly 15 percent of all chewing gum varieties sold promise to provide health-enhancing supplements to users, so Penn State researchers studied whether two vitamin-supplemented products were effective at delivering vitamins to the body. Their results validate the concept of gum as an effective delivery system for at least some vitamins.
› Verified 1 days ago
| Entity Name | Valley Medical Group-renton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619209574 PECOS PAC ID: 4183753965 Enrollment ID: O20100604000113 |
News Archive
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
Family-based treatments are effective for substance abuse and conduct disorders in children and adolescents, according to a new, ten-year research review released this week. The treatment also helps reduce the behavior problems associated with attention deficit hyperactivity disorder (ADHD) and shows promise in treating depression and anxiety.
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.
Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos.
Nearly 15 percent of all chewing gum varieties sold promise to provide health-enhancing supplements to users, so Penn State researchers studied whether two vitamin-supplemented products were effective at delivering vitamins to the body. Their results validate the concept of gum as an effective delivery system for at least some vitamins.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shamim Hashemi Nejad, MD 3600 Lind Ave Sw, Suite 100 Attn Credentialing, Renton, WA 98057-4970 Ph: (425) 690-2715 | Shamim Hashemi Nejad, MD 4445 Talbot Rd S, Renton, WA 98055-6219 Ph: (425) 690-3414 |
News Archive
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
Family-based treatments are effective for substance abuse and conduct disorders in children and adolescents, according to a new, ten-year research review released this week. The treatment also helps reduce the behavior problems associated with attention deficit hyperactivity disorder (ADHD) and shows promise in treating depression and anxiety.
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.
Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitos.
Nearly 15 percent of all chewing gum varieties sold promise to provide health-enhancing supplements to users, so Penn State researchers studied whether two vitamin-supplemented products were effective at delivering vitamins to the body. Their results validate the concept of gum as an effective delivery system for at least some vitamins.
› Verified 1 days ago
Don Q. Thai, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3915 Talbot Rd S, Ste 104, Renton, WA 98055 Phone: 425-917-6218 Fax: 425-917-6287 | |
Emily Jane Wingfield, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4445 Talbot Rd S, Renton, WA 98055 Phone: 425-656-4055 Fax: 425-656-5425 | |
Nam H Nguyen, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4445 Talbot Rd S, Renton, WA 98055 Phone: 425-656-4055 Fax: 425-656-5425 | |
Wojciech Gryc, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-690-3585 Fax: 425-690-9585 | |
Dr. Ali Sultan-qurraie, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-656-5566 Fax: 425-656-5567 | |
Jeannie C Hu, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 912 N 1st St, Renton, WA 98057 Phone: 425-207-3798 |